Works matching IS 20445385 AND DT 2024 AND VI 14 AND IP 1

Results: 226
    1
    2
    3

    Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01200-w
    By:
    • Malard, Florent;
    • Bobin, Arthur;
    • Labopin, Myriam;
    • Karlin, Lionel;
    • Frenzel, Laurent;
    • Roussel, Murielle;
    • Vignon, Marguerite;
    • Godet, Sophie;
    • Chalopin, Thomas;
    • Moyer, Perrine;
    • Chalayer, Emilie;
    • Orsini Piocelle, Frederique;
    • Mariette, Clara;
    • Croizier, Carolyne;
    • Sohn, Claudine;
    • Dib, Mamoun;
    • Le Calloch, Ronan;
    • Ali-Ammar, Nadia;
    • Loirat, Marion;
    • Benbrahim, Omar
    Publication type:
    Article
    4

    Single-cell transcriptomic and spatial analysis reveal the immunosuppressive microenvironment in relapsed/refractory angioimmunoblastic T-cell lymphoma.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01199-0
    By:
    • Zhu, Mengyan;
    • Li, Ning;
    • Fan, Lei;
    • Wu, Rongrong;
    • Cao, Lei;
    • Ren, Yimin;
    • Lu, Chuanyang;
    • Zhang, Lishen;
    • Cai, Yun;
    • Shi, Yuzhu;
    • Lin, Zihan;
    • Lu, Xueying;
    • Leng, Jiayan;
    • Zhong, Shiyang;
    • Hu, Xingfei;
    • Huang, Bin;
    • Huang, Runheng;
    • Zhou, Wanting;
    • Yao, Diru;
    • Wu, Lingxiang
    Publication type:
    Article
    5
    6
    7
    8

    Expanded tumor-associated polymorphonuclear myeloid-derived suppressor cells in Waldenstrom macroglobulinemia display immune suppressive activity.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01173-w
    By:
    • Bhardwaj, Vaishali;
    • Yang, Zhi-Zhang;
    • Jalali, Shahrzad;
    • Villasboas, Jose C.;
    • Mudappathi, Rekha;
    • Wang, Junwen;
    • Mukherjee, Prithviraj;
    • Paludo, Jonas;
    • Tang, Xinyi;
    • Kim, Hyo Jin;
    • Krull, Jordan E.;
    • Wenzl, Kerstin;
    • Novak, Anne J.;
    • Mondello, Patrizia;
    • Ansell, Stephen M.
    Publication type:
    Article
    9
    10
    11
    12

    Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01197-2
    By:
    • Merz, Maximilian;
    • Dima, Danai;
    • Hashmi, Hamza;
    • Ahmed, Nausheen;
    • Stölzel, Friedrich;
    • Holderried, Tobias A. W.;
    • Fenk, Roland;
    • Müller, Fabian;
    • Tovar, Natalia;
    • Oliver-Cáldes, Aina;
    • Rathje, Kristin;
    • Davis, James A.;
    • Fandrei, David;
    • Vucinic, Vladan;
    • Kharboutli, Soraya;
    • Baermann, Ben-Niklas;
    • Ayuk, Francis;
    • Platzbecker, Uwe;
    • Albici, Anca-Maria;
    • Schub, Nathalie
    Publication type:
    Article
    13

    High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01185-6
    By:
    • Martello, Marina;
    • Solli, Vincenza;
    • Mazzocchetti, Gaia;
    • Solimando, Antonio Giovanni;
    • Bezzi, Davide;
    • Taurisano, Barbara;
    • Kanapari, Ajsi;
    • Poletti, Andrea;
    • Borsi, Enrica;
    • Armuzzi, Silvia;
    • Vigliotta, Ilaria;
    • Pistis, Ignazia;
    • Desantis, Vanessa;
    • Marzocchi, Giulia;
    • Rizzello, Ilaria;
    • Pantani, Lucia;
    • Mancuso, Katia;
    • Tacchetti, Paola;
    • Testoni, Nicoletta;
    • Nanni, Cristina
    Publication type:
    Article
    14

    Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01149-w
    By:
    • Richardson, Paul G.;
    • Perrot, Aurore;
    • Mikhael, Joseph;
    • Martin, Thomas;
    • Beksac, Meral;
    • Spicka, Ivan;
    • Capra, Marcelo;
    • D'Agostino, Mattia;
    • Sonneveld, Pieter;
    • Bisht, Kamlesh;
    • Fukao, Taro;
    • Zhang, Rick;
    • Tada, Keisuke;
    • Tekle, Christina;
    • Macé, Sandrine;
    • Klippel, Zandra;
    • van de Velde, Helgi;
    • Moreau, Philippe
    Publication type:
    Article
    15
    16

    RSK1 dependency in FLT3-ITD acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01187-4
    By:
    • Kong, Tim;
    • Laranjeira, Angelo B. A.;
    • Letson, Christopher T.;
    • Yu, LaYow;
    • He, Fan;
    • Jayanthan, Aarthi;
    • Los, Gerrit;
    • Dunn, Sandra E.;
    • Challen, Grant A.;
    • Oh, Stephen T.
    Publication type:
    Article
    17

    Indolent nodal T follicular helper cell lymphomas—A case series.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01163-y
    By:
    • Wang, Jie;
    • Yau, Chun En;
    • Low, Chen Ee;
    • Bin Hasan Mohamed, Mohamed Haniffa;
    • Cheng, Chee Leong;
    • Neff, Jadee L.;
    • Lim, Jing Quan;
    • Lim, Soon Thye;
    • Chan, Jason Yongsheng;
    • Ong, Choon Kiat;
    • Yang, Valerie Shiwen
    Publication type:
    Article
    18

    Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01189-2
    By:
    • Suo, Xiaohui;
    • Ma, Xiaojun;
    • Zheng, Fang;
    • Wang, Dongmei;
    • Bai, Guanchen;
    • Zhao, Liyun;
    • Han, Zhongjing;
    • Lv, Xin;
    • Zhang, Congcong;
    • Wang, Ju;
    • Tuo, Kangxin;
    • Meng, Zhen;
    • Liu, Shan;
    • Gao, Sifeng;
    • Zhang, Jilei;
    • Jiao, Zongjiu;
    • Song, Jiaojie;
    • Li, Ling;
    • Lu, Xinxiao;
    • Yuan, Linyu
    Publication type:
    Article
    19

    What have we learned about TP53-mutated acute myeloid leukemia?

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01186-5
    By:
    • Shahzad, Moazzam;
    • Amin, Muhammad Kashif;
    • Daver, Naval G.;
    • Shah, Mithun Vinod;
    • Hiwase, Devendra;
    • Arber, Daniel A.;
    • Kharfan-Dabaja, Mohamed A.;
    • Badar, Talha
    Publication type:
    Article
    20
    21
    22
    23

    Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL).

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01175-8
    By:
    • Sekar, Aswin;
    • Griffin, Rosalie;
    • Parikh, Sameer A.;
    • Genovese, Giulio;
    • Robinson, Dennis P.;
    • Norman, Aaron D.;
    • Olson, Janet E.;
    • Rabe, Kari G.;
    • Hoel, Mingma S.;
    • Boddicker, Nicholas J.;
    • Hampel, Paul J.;
    • Kay, Neil E.;
    • Cerhan, James R.;
    • Braggio, Esteban;
    • Hanson, Curtis A.;
    • Vachon, Celine M.;
    • Shanafelt, Tait D.;
    • Ebert, Benjamin L.;
    • Slager, Susan L.
    Publication type:
    Article
    24

    Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01172-x
    By:
    • Cheng, Yan;
    • Sun, Fumou;
    • Alapat, Daisy V.;
    • Wanchai, Visanu;
    • Mery, David;
    • Siegel, Eric R.;
    • Xu, Hongwei;
    • Johnson, Sarah;
    • Guo, Wancheng;
    • Bailey, Clyde;
    • Ashby, Cody;
    • Bauer, Michael Anton;
    • Hadidi, Samer Al;
    • Schinke, Carolina;
    • Thanendrarajan, Sharmilan;
    • Zangari, Maurizio;
    • van Rhee, Frits;
    • Tricot, Guido;
    • Shaughnessy Jr, John D.;
    • Zhan, Fenghuang
    Publication type:
    Article
    25

    Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01181-w
    By:
    • Giaccherini, Matteo;
    • Clay-Gilmour, Alyssa I.;
    • Liotti, Romano;
    • Macauda, Angelica;
    • Gentiluomo, Manuel;
    • Brown, Elizabeth E.;
    • Machiela, Mitchell J.;
    • Chanock, Stephen J.;
    • Hildebrandt, Michelle A. T.;
    • Norman, Aaron D.;
    • Manasanch, Elisabet;
    • Rajkumar, S. Vincent;
    • Hofmann, Jonathan N.;
    • Berndt, Sonja I.;
    • Bhatti, Parveen;
    • Giles, Graham G.;
    • Ziv, Elad;
    • Kumar, Shaji K.;
    • Camp, Nicola J.;
    • Cozen, Wendy
    Publication type:
    Article
    26
    27

    The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01180-x
    By:
    • Toscan, Cara E.;
    • McCalmont, Hannah;
    • Ashoorzadeh, Amir;
    • Lin, Xiaojing;
    • Fu, Zhe;
    • Doculara, Louise;
    • Kosasih, Hansen J.;
    • Cadiz, Roxanne;
    • Zhou, Anthony;
    • Williams, Sarah;
    • Evans, Kathryn;
    • Khalili, Faezeh;
    • Cai, Ruilin;
    • Yeats, Kristy L.;
    • Gifford, Andrew J.;
    • Pickford, Russell;
    • Mayoh, Chelsea;
    • Xie, Jinhan;
    • Henderson, Michelle J.;
    • Trahair, Toby N.
    Publication type:
    Article
    28
    29

    Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01177-6
    By:
    • Ailawadhi, Sikander;
    • Lee, Hans C.;
    • Omel, James;
    • Toomey, Kathleen;
    • Hardin, James W.;
    • Gasparetto, Cristina J.;
    • Jagannath, Sundar;
    • Rifkin, Robert M.;
    • Durie, Brian G. M.;
    • Narang, Mohit;
    • Terebelo, Howard R.;
    • Joshi, Prashant;
    • Jou, Ying-Ming;
    • Mouro, Jorge;
    • Yu, Edward;
    • Abonour, Rafat
    Publication type:
    Article
    30

    Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01183-8
    By:
    • Di Staso, Rossana;
    • Casadei, Beatrice;
    • Locke, Frederick L.;
    • Jain, Michael;
    • Voorhees, Timothy J.;
    • Kittai, Adam S.;
    • Bastos-Oreiro, Mariana;
    • Gutiérrez, Antonio;
    • Martin Garcia-Sancho, Alejandro;
    • Terol, Maria Jose;
    • Mead, Monica;
    • Maranzano, Michael J.;
    • Iacoboni, Gloria;
    • Barba, Pere;
    • Kwon, Mi;
    • Bailen, Rebeca;
    • Reguera-Ortega, Juan Luis;
    • Mian, Agrima;
    • Hill, Brian;
    • Bachy, Emmanuel
    Publication type:
    Article
    31

    Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01178-5
    By:
    • Shimony, Shai;
    • Raman, Hari S.;
    • Flamand, Yael;
    • Keating, Julia;
    • Paolino, Jonathan D.;
    • Valtis, Yannis K.;
    • Place, Andrew E.;
    • Silverman, Lewis B.;
    • Sallan, Stephen E.;
    • Vrooman, Lynda M.;
    • Brunner, Andrew M.;
    • Neuberg, Donna S.;
    • Galinsky, Ilene;
    • Garcia, Jacqueline S.;
    • Winer, Eric S.;
    • Wadleigh, Martha;
    • Stone, Richard M.;
    • Connors, Jean M.;
    • DeAngelo, Daniel J.;
    • Luskin, Marlise R.
    Publication type:
    Article
    32
    33

    Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01165-w
    By:
    • Pasvolsky, Oren;
    • Marcoux, Curtis;
    • Milton, Denái R.;
    • Pal, Babar;
    • Tanner, Mark R.;
    • Bashir, Qaiser;
    • Srour, Samer;
    • Lee, Jaehyun;
    • Saini, Neeraj;
    • Lin, Paul;
    • Ramdial, Jeremy;
    • Nieto, Yago;
    • Tang, Guilin;
    • Aljawai, Yosra;
    • Kebriaei, Partow;
    • Becnel, Melody R.;
    • Lee, Hans C.;
    • Patel, Krina K.;
    • Thomas, Sheeba K.;
    • Orlowski, Robert Z.
    Publication type:
    Article
    34
    35
    36

    The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01142-3
    By:
    • Zhang, Ronghua;
    • Khare, Priyanka;
    • Banerjee, Priyanka;
    • Ivan, Cristina;
    • Schneider, Sarah;
    • Barbaglio, Federica;
    • Clise-Dwyer, Karen;
    • Jensen, Vanessa Behrana;
    • Thompson, Erika;
    • Mendoza, Marisela;
    • Chiorazzi, Nicholas;
    • Chen, Shih-Shih;
    • Yan, Xiao-Jie Joy;
    • Jain, Nitin;
    • Ghia, Paolo;
    • Caligaris-Cappio, Federico;
    • Mendonsa, Rima;
    • Kasimsetty, Sashi;
    • Swoboda, Ryan;
    • Bayraktar, Recep
    Publication type:
    Article
    37
    38
    39
    40
    41
    42

    Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01162-z
    By:
    • Grover, Natalie S.;
    • Annunzio, Kaitlin;
    • Watkins, Marcus;
    • Torka, Pallawi;
    • Karmali, Reem;
    • Anampa-Guzmán, Andrea;
    • Oh, Timothy S.;
    • Reves, Heather;
    • Tavakkoli, Montreh;
    • Hansinger, Emily;
    • Christian, Beth;
    • Thomas, Colin;
    • Barta, Stefan K.;
    • Geethakumari, Praveen Ramakrishnan;
    • Bartlett, Nancy L.;
    • Shouse, Geoffrey;
    • Olszewski, Adam J.;
    • Epperla, Narendranath
    Publication type:
    Article
    43

    Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01167-8
    By:
    • Fortuna, Gliceida Galarza;
    • Banerjee, Rahul;
    • Savid-Frontera, Constanza;
    • Song, Jinming;
    • Morán-Segura, Carlos M.;
    • Nguyen, Jonathan V.;
    • Lekakis, Lazaros;
    • Fernandez-Pol, Sebastian;
    • Samraj, Annie N.;
    • Naresh, Kikkeri N.;
    • Vazquez-Martinez, Mariola;
    • Baz, Rachid C.;
    • Spiegel, Jay Y.;
    • Mikkilineni, Lekha;
    • Gubatan, John M.;
    • Sidana, Surbhi;
    • de Menezes Silva Corraes, Andre;
    • Kalariya, Nilesh M.;
    • Patel, Krina K.;
    • Shim, Kevin G.
    Publication type:
    Article
    44
    45
    46
    47
    48

    Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01154-z
    By:
    • Morice, Pierre-Marie;
    • Khalife-Hachem, Sabine;
    • Sassier, Marion;
    • Lelong-Boulouard, Véronique;
    • Danu, Alina;
    • Pasquier, Florence;
    • Renneville, Aline;
    • Dolladille, Charles;
    • Micol, Jean-Baptiste
    Publication type:
    Article
    49

    Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01148-x
    By:
    • Lue, Jennifer K.;
    • Luttwak, Efrat;
    • Rivas-Delgado, Alfredo;
    • Irawan, Helen;
    • Boardman, Alexander;
    • Caron, Philip C.;
    • David, Kevin;
    • Epstein-Peterson, Zachary;
    • Falchi, Lorenzo;
    • Ghione, Paola;
    • Hamlin, Paul;
    • Horwitz, Steven M.;
    • Intlekofer, Andrew M.;
    • Johnson, William;
    • Kumar, Anita;
    • Moskowitz, Alison;
    • Noy, Ariela;
    • Palomba, M. Lia;
    • Steiner, Ralphael;
    • Stuver, Robert
    Publication type:
    Article
    50